Mechanistic Study and Therapeutic Strategy of HDAC6 Regulates EGFR Signaling in Hepatocellular Carcinoma
碩士 === 輔英科技大學 === 醫學檢驗生物技術系碩士班 === 102 === In Taiwan, hepatocellular carcinoma (HCC) is the second most common cause of cancer death and causes more than 7,500 deaths each year. Nevertheless, approximately 75% of patients with HCC have advanced unresectable diseases upon presentation. Alterations of...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | zh-TW |
Published: |
2014
|
Online Access: | http://ndltd.ncl.edu.tw/handle/19778475173548538156 |